reserves the right to clarify each author’s role, based upon information collected from authors in connection with their submission.For large, randomized, multicenter, controlled trials, different authors may share responsibilities and separately attest to these: "Dr.XYZ has personally reviewed the efficacy data, understands the statistical methods employed for efficacy analysis, and confirms an understanding of this analysis, that the methods are clearly described and that they are a fair way to report the results." "Dr. (S)he understands the statistical methods employed for safety analysis and confirms that (s)he understands this analysis, that the methods are clearly described, and that they are a fair way to report the results." Furthermore, (s)he has personally reviewed the Serious Adverse Events occurring in ≥ 0.1% of participants per treatment group and confirms that these are fairly disclosed and analyzed even in the presence of uncertainty with respect to relationship to treatment." "Dr.
Moreover, (s)he has reviewed study execution data and confirms that procedures were followed to an extent that convinces all authors that the results are valid and generalizable to a population similar to that enrolled in this study." If a group name is used in a byline and the members of the group qualify for authorship, the group name in the byline should be followed by an asterisk (*).
The asterisk in the byline corresponds to another asterisk in a section titled Writing Committee Members for XXX (group name).
Pub Med will index these individuals as collaborators.
This section should fall in the Acknowledgments section.
It should be titled Writing Committee Members for XXX (group name) and list the names and affiliations of all those in the group.